Literature DB >> 20967866

Oncologic and functional results after transhyoid surgical approach for cancer of the base of tongue.

Juan P Rodrigo1, Juan Pablo Díaz-Molina, Carla Moreno, Carlos Suárez.   

Abstract

BACKGROUND: The optimal treatment for base of tongue cancer remains unclear, especially in advanced stages.
METHODS: We retrospectively review 84 previously untreated patients that underwent a transhyoid resection of a base of tongue carcinoma. Sixty-four patients (76%) underwent postoperative radiotherapy.
RESULTS: Five patients had stage II disease, 6 had stage III, 58 had stage IVA, and 15 had stage IVB. The overall recurrence rate was 68%. Five-year disease-specific survival rates by stage were 100%, 67%, 27%, and 8% for stage II to IVB, respectively (p = .0007). Multivariate analysis showed that the presence of lymph node metastases was an independent predictor of reduced disease-specific survival rates (p = .02). All patients maintained an intelligible voice, and oral alimentation was successfully recovered in 97.5% of them.
CONCLUSIONS: The transhyoid approach allowed adequate resection of base of tongue cancers with low morbidity and acceptable functional results, but the oncologic outcomes in advanced stages are poor. Head Neck, 2011.
Copyright © 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20967866     DOI: 10.1002/hed.21569

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  2 in total

1.  Anatomical landmarks for transoral robotic tongue base surgery: comparison between endoscopic, external and radiological perspectives.

Authors:  Iacopo Dallan; Veronica Seccia; Lorenzo Faggioni; Paolo Castelnuovo; Filippo Montevecchi; Augusto Pietro Casani; Manfred Tschabitscher; Claudio Vicini
Journal:  Surg Radiol Anat       Date:  2012-05-29       Impact factor: 1.246

2.  Oncologic and functional results after transoral laser microsurgery of tongue base carcinoma.

Authors:  Martin Canis; Friedrich Ihler; Hendrik A Wolff; Hans Christiansen; Christoph Matthias; Wolfgang Steiner
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-07-05       Impact factor: 2.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.